结构化放射学报告的实施及其与胰腺多学科门诊专家影像复核相比的准确性
单机构前瞻性队列研究于2022年3月至2024年5月在高通量胰腺多学科门诊(PMDC)评估结构化报告(SR)实施的可行性,以PMDC专家影像复核为金标准,比较SR与自由文本报告在胰腺原发肿瘤血管受累判定上的准确性;多变量分析显示使用SR使PMDC复核时血管受累增加的优势降低0.29倍。
要点
- SR使用率从2022年3月的58.3%升至2024年6月的87.8%。
- 非SR报告在PMDC复核时血管受累被上调的比例为62.5%(20/32),SR报告为36.6%(48/132)。
- 使用SR使PMDC复核时血管受累增加的比值降低0.29倍(95%CI 0.11-0.79;p=0.015)。
核心结论
- SR在该中心可行,且在胰腺周围血管受累判定的准确性上优于自由文本报告;SR不能替代PMDC影像复核,但尤其在非PMDC场景下可作为临床管理中不可或缺的工具。
研究设计与样本
- 单机构前瞻性队列研究,2022年3月至2024年5月纳入466例PMDC患者,其中426例(91.4%)在PMDC前生成报告,294份报告符合纳入标准。
关键影像表现/征象
- 与放射科报告相比,PMDC复核时非SR报告有62.5%(20/32)出现血管受累增加,SR报告仅36.6%(48/132)出现血管受累增加。
诊断标准与关键数值
- 以PMDC专家放射科复核为金标准,判断放射科报告与复核之间胰腺原发肿瘤血管受累的差异。
- 多变量分析显示使用SR使PMDC复核时血管受累增加的优势降低0.29倍(95%CI 0.11-0.79;p=0.015)。
临床应用与阅片要点
- SR主要用于胰腺癌初始分期(n=197,67.0%)及使用SR报告中的多数(n=226,76.9%)。
- 使用非SR的阅片医师中位经验为14年(IQR 8-27),使用SR者为9年(IQR 9-15)(p=0.030)。
- 作者认为SR不能替代PMDC影像复核,但在非PMDC场景下可作为临床管理中不可或缺的工具。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate the feasibility of implementation of structured reporting in the setting of a high-volume pancreatic multidisciplinary clinic (PMDC) and to assess its value by comparing the accuracy of structured reports with expert imaging reviews.
METHODS: A single institutional prospective cohort study was conducted during March 2022 to May 2024 to understand the feasibility of implementation of structured reporting (SR) for all patients who were seen in our weekly PMDC. Descriptive and regression analyses were performed to find an association between SR and difference in vascular involvement of the primary pancreatic tumor between the radiology report and expert radiologist review (gold standard) during PMDC.
RESULTS: Among 466 patients seen in the PMDC, 426 (91.4%) had reports generated prior to PMDC. Of this, 294 reports met the inclusion criteria. The usage of SR increased from 58.3% in Mar 2022 to 87.8% in June 2024. Majority of the reports that used SR (n = 226, 76.9%), were performed for initial staging (n = 197, 67.0%) of PC. The median years of experience of reading radiologists that used non-SR was 14 (IQR: 8-27) years, while it was 9 (IQR - 9-15) years for those who used SR (p = 0.030). Of note, as compared to the radiology report, increased vascular involvement was noted in PMDC review 62.5% (20 out of 32) of the time with non-SRs, whereas increased vascular involvement during PMDC review was noted in only 36.6% (48 out of 132) of the time with SRs. On multivariable analysis, using SR lowered the odds of increase in vascular involvement during PMDC review by 0.29 times (95CIs 0.11-0.79; p = 0.015).
CONCLUSION: SR is feasible and superior to the free-text reporting with respect to the accuracy of peri-pancreatic vascular involvement. While its use cannot replace the PMDC radiology review, it can nonetheless be an indispensable tool in clinical management, particularly in a non-PMDC setting.
引用
- Pathak P, Hacker-Prietz A, Myneni R, et al. Implementation of structured radiology reporting and its associated accuracy in comparison to pancreas multi-disciplinary clinic expert radiology review. Abdom Radiol (NY). 2024. PMID: 39532733. doi:10.1007/s00261-024-04646-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。